source
- Lilly obesity meds Foundayo and Zepbound to gain CVS coverageEli Lilly’s flagship obesity medications will be included in CVS Caremark formularies, likely boosting sales in the most competitive commercial drug market. The company announced Thursday that its…Endpoints · 2mo ago↗ source
- GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.BioPharma Dive · 2mo ago↗ source
- For wearables, it’s a GLP-1 worldWe have two pieces of wearables-related news for you today, and (maybe unsurprisingly) GLP-1s came up in our conversations with both companies. First, Signos raised $20 million for its approach ...